ETFs Edwards Lifesciences Corporation

EW

US28176E1082

Advanced Medical Equipment & Technology

Market Closed - NYSE 00:00:03 29/10/2026 +04			5-day change	1st Jan Change
91.78 ^USD	+1.06%		+3.82%	+7.66%

10-21	Edwards Lifesciences Corporation Receives FDA Approval For PASCAL Precision System For Tricuspid Valve Repair And PASCAL Ace With Capture Clarity System For Degenerative Mitral TEER Procedures	CI
10-21	Edwards Lifesciences Gets Approval for Tricuspid Valve Repair System From US FDA	MT

ETFs positioned on Edwards Lifesciences Corporation

Name	YTD change	Weight	AuM
PACER PE/VC ETF - USD	+11.53%	-	3 M€
SOUNDWATCH HEDGED EQUITY ETF - USD	+4.60%	-	165 M€
UBS MSCI USA SELECT FACTOR MIX UCITS ETF (HEDGED TO CHF) A-ACC - CHF	+9.15%	-	28 M€
UNLIMITED HFND MULTI-STRATEGY RETURN TRACKER ETF - USD	+5.59%	-	37 M€
FUNDX CONSERVATIVE ETF - USD	+6.23%	-	49 M€
UBS MSCI WORLD EX USA CLIMATE PARIS ALIGNED UCITS ETF A-ACC - USD	+12.50%	-	66 M€
HSBC MSCI WORLD UCITS ETF (C) - USD	+17.94%	-	2,303 M€
UBS MSCI ACWI CLIMATE PARIS ALIGNED UCITS ETF ACC - USD	+13.50%	-	122 M€
CI GROWTH ASSET ALLOCATION ETF -CAD	+9.73%	-	67 M€
UBS S&P 500 ESG ELITE UCITS ETF A-ACC - EUR HEDGED	+21.24%	-	272 M€
STATE STREET SPDR S&P WORLD EX AUSTRALIA CARBON AWARE (HEDGED) ETF - AUD	+1.96%	-	293 M€
BNP PARIBAS EASY S&P 500 SCORED AND SCREENED UCITS ETF - EUR	+18.44%	-	669 M€
DIMENSIONAL WORLD EQUITY ETF - USD	+13.44%	-	1,674 M€
VANECK BIONIC ENGINEERING UCITS ETF - USD	+0.65%	9.58%	13 M€
ISHARES U.S. MEDICAL DEVICES ETF - USD	-12.08%	4.79%	3,478 M€
ISHARES US MEDICAL DEVICES UCITS ETF (ACC) - USD	-12.35%	3.98%	234 M€
GLOBAL X AGING POPULATION ETF - USD	+7.42%	3.04%	94 M€
ISHARES HEALTH INNOVATION ACTIVE ETF - USD	+19.18%	2.64%	13 M€
BMO US PUT WRITE ETF - CAD	+3.63%	2.46%	77 M€
FIDELITY DISRUPTIVE MEDICINE ETF - USD	+22.87%	2.4%	49 M€
NOMURA NEXT FUNDS INTERNATIONAL EQUITY MSCI-KOKUSAI (YEN-HEDGED) ETF - JPY	+8.87%	2.34%	61 M€
PROSHARES MSCI TRANSFORMATIONAL CHANGES ETF - USD	+8.82%	2.02%	8 M€
JPMORGAN HEALTHCARE LEADERS ETF - USD	+10.71%	1.93%	9 M€
TEMA GLP-1, OBESITY & CARDIOMETABOLIC ETF - USD	+6.94%	1.88%	56 M€
STATE STREET SPDR S&P HEALTH CARE EQUIPMENT ETF - USD	+6.59%	1.78%	176 M€
L&G HEALTHCARE TECHNOLOGY & INNOVATION UCITS ETF - USD	+31.49%	1.66%	303 M€

1 2 3 4 5

Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows: - heart valves and surgery products (74%); - hemodynamic monitoring systems (9.1%); - other (16.9%): balloon catheters, artificial implants, etc. Net sales are distributed geographically as follows: the United States (58.4%), Europe (25%), Japan (5.8%) and other (10.8%).

Employees

16,000

Sector

Advanced Medical Equipment & Technology

Calendar

11-05 Earnings release - Q3 2026

More about the company